New insights into the molecular structure of the dihydropyridine-sensitive calcium channel

Calcium channel ligand binding to intact, concanavalin A and cyclic AMP-treated cells of the immune system

To examine whether the cells of immune system express calcium channel-forming proteins, we studied the binding of calcium channel ligands, known to detect certain types of the above channels in excitable tissues, to murine splenic and human peripheral blood mononuclear cells. Specific (i.e., displaceable by excess cold ligand) binding of the 3H-labelled dihydropyridine drugs PN200-110 and nitrendipine, was not detected in these cells. Specific binding of a phenylalkylamine drug, [3H]verapamil, was detected, but cannot be attributed to the existence of certain specialized receptors, since multiple [3H]verapamil binding sites (about 10(6) per cell) appeared to be occupied. [3H]Verapamil binding to murine splenic mononuclear cells was inhibited following exposure to either the polyclonal T-cell activator, concanavalin A, or a cell-permeable analogue of the second messenger, cyclic AMP, suggesting that processes of lymphocyte activation and/or intracellular signalling may down-modulate at least some of calcium channel ligand binding sites.

Structural and functional aspects of calcium homeostasis in eukaryotic cells

The maintenance of a low cytosolic free-Ca2+ concentration, ([Ca2+]i) is a common feature of all eukaryotic cells. For this purpose a variety of mechanisms have developed during evolution to ensure the buffering of Ca2+ in the cytoplasm, its extrusion from the cell and/or its accumulation within organelles. Opening of plasma membrane channels or release of Ca2+ from intracellular pools leads to elevation of [Ca2+]i; as a result, Ca2+ binds to cytosolic proteins which translate the changes in [Ca2+]i into activation of a number of key cellular functions. The purpose of this review is to provide a comprehensive description of the structural and functional characteristics of the various components of [Ca2+]i homeostasis in eukaryotes.

The role of calcium in Chlamydomonas photomovement responses as analysed by calcium channel inhibitors

Phototaxis and light-induced stop responses in Chlamydomonas are known to be calcium dependent. We show that phototaxis is stereoselectively inhibited by dihyropyridines, verapamil, diltiazem, omega-conotoxin and pimozide, all inhibitors of slow L-type calcium channels. In contrast, the stop response in Chlamydomonas can be specifically reduced only by omega-conotoxin and pimozide. The light-regulated calcium uptake as detected by 45calcium can be completely suppressed by verapamil and omega-conotoxin but not by diltiazem or any of the dihyropyridine-type calcium channel inhibitors. We conclude that phototaxis and stop response in Chlamydomonas are regulated by three distinguishable drug receptor sites. One of them controls phototaxis and is sensitive to verapamil. The second site controls stop response and phototaxis and shows a high sensitivity to omega-conotoxin and pimozide. These two drug receptors seem to be localized in the plasma membrane and function as ion channels. In addition, calcium influences internal signal transduction from the photoreceptor to the flagella. This internal role of calcium is inhibited by the dihydropyridine binding to a dihydropyridine receptor protein. The arylazide-1,4-dihydropyridine[3H]azidopine binds with a Kd = 35 nM to a 50 kDa protein located in one of the internal cell membranes. Azidopine binding is fully reversible and can be partially inhibited by nimodipine and PN-200110. This protein is the first identified dihyropyridine receptor in an unicellular plant cell. It might serve as an internal calcium regulating channel in Chlamydomonas.

The alpha 1 and alpha 2 polypeptides of the dihydropyridine-sensitive calcium channel differ in developmental expression and tissue distribution

The dihydropyridine (DHP) binding complex isolated from skeletal muscle contains two large proteins, alpha 1 and alpha 2, and at least two smaller polypeptides. The alpha 1 subunit has a primary structure expected for ion channels and is a functional component of a DHP-sensitive, voltage-activated calcium channel. The functions of the alpha 2 protein and the smaller polypeptides are unknown. We prepared monoclonal antibodies to the alpha 1 and alpha 2 polypeptides and studied the developmental appearance and tissue distribution of these two proteins. In rat skeletal muscle, the levels of alpha 1 are quite low during the first 10 days after birth, then rise dramatically, and, by day 20, approach those found in adult muscle. In direct contrast, alpha 2 is present in substantial amounts in rat muscle at birth and increases only slightly during this same period of development. Furthermore, alpha 1 is detected only in skeletal muscle, whereas alpha 2 is present in a variety of tissues. These results provide evidence for the segregation of these two polypeptides and suggest that the function of alpha 2 is not limited to that associated with the DHP-sensitive calcium channel.

Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel

Complementary DNAs were isolated and used to deduce the primary structures of the alpha 1 and alpha 2 subunits of the dihydropyridine-sensitive, voltage-dependent calcium channel from rabbit skeletal muscle. The alpha 1 subunit, which contains putative binding sites for calcium antagonists, is a hydrophobic protein with a sequence that is consistent with multiple transmembrane domains and shows structural and sequence homology with other voltage-dependent ion channels. In contrast, the alpha 2 subunit is a hydrophilic protein without homology to other known protein sequences. Nucleic acid hybridization studies suggest that the alpha 1 and alpha 2 subunit mRNAs are expressed differentially in a tissue-specific manner and that there is a family of genes encoding additional calcium channel subtypes.